A systematic analysis of the 3′utr of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wirsing, Andrea ^a   Senkel, Sabine ^a   Klein Hitpass, Ludger ^a   Ryffel, Gerhart U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; MICRORNA; MICRORNA 21; MICRORNA 34A; UNCLASSIFIED DRUG; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; RIBONUCLEASE III;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE REPRESSION; HNF4A GENE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MATURITY ONSET DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; REGULATORY SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CELL STRAIN HEK293; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MOLECULAR GENETICS; POLYADENYLATION; REPORTER GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HEK293 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYADENYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; RIBONUCLEASE III; RNA, MESSENGER;

EID: 82355171192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027438     Document Type: Article

References (79)

1. Bolotin E, Schnabl JM, Sladek FM, (2010) HNF4A (Homo sapiens). Transcription Factor Encyclopedia Available:http://www.cisreg.ca/tfe. Accessed 2010 July 15.
2. Bolotin E, Sladek FM, Schnabl JM, (2010) Hnf4a (Mus musculus). Transcription Factor Encyclopedia Available: http://www.cisreg.ca/tfe. Accessed 2010 July 15.
3. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, et al. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303: 1378-1381.
4. Erdmann S, Senkel S, Arndt T, Lucas B, Lausen J, et al. (2007) Tissue-specific transcription factor HNF4alpha inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 beta-cell line. Biol Chem 388: 91-106.
5. Grigo K, Wirsing A, Lucas B, Klein-Hitpass L, Ryffel GU, (2008) HNF4alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 389: 179-187.
6. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, et al. (2010) Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 51: 642-653.
7. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, et al. (2004) Genetic Variation Near the Hepatocyte Nuclear Factor-4alpha Gene Predicts Susceptibility to Type 2 Diabetes. Diabetes 53: 1141-1149.
8. Love-Gregory L, Permutt MA, (2007) HNF4A genetic variants: role in diabetes. Curr Opin Clin Nutr Metab Care 10: 397-402.
9. Ryffel GU, (2001) Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27: 11-29.
10. Gupta RK, Kaestner KH, (2004) HNF-4alpha: from MODY to late-onset type 2 diabetes. Trends Mol Med 10: 521-524.
11. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, et al. (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047.
12. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, et al. (2008) Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 48: 1528-1539.
13. Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, et al. (2003) Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 3: 31.
14. Sel S, Ebert T, Ryffel GU, Drewes T, (1996) Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha. Cancer Lett 101: 205-210.
15. Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, et al. (2005) Activation of p21(CIP1/WAF1) gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Exp Cell Res 302: 11-21.
16. Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, et al. (2005) HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 24: 6418-6431.
17. Nakhei H, Lingott A, Lemm I, Ryffel GU, (1998) An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. Nucleic Acids Res 26: 497-504.
18. Thomas H, Jaschkowitz K, Bulman M, Frayling TM, Mitchell SM, et al. (2001) A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 10: 2089-2097.
19. Huang J, Levitsky LL, Rhoads DB, (2009) Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion. Exp Cell Res 315: 1200-1211.
20. Wirsing A, Johnstone KA, Harries LW, Ellard S, Ryffel GU, et al. (2010) Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro. Diabet Med 27: 631-635.
21. Harries LW, Locke JM, Shields B, Hanley NA, Hanley KP, et al. (2008) The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes 57: 1745-1752.
22. Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M, et al. (2000) Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 28: 430-437.
23. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, et al. (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463: 360-363.
24. Grzybowska EA, Wilczynska A, Siedlecki JA, (2001) Regulatory functions of 3′UTRs. Biochem Biophys Res Commun 288: 291-295.
25. Chatterjee S, Pal JK, (2009) Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell 101: 251-262.
26. de Moor CH, Meijer H, Lissenden S, (2005) Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol 16: 49-58.
27. Moore MJ, (2005) From birth to death: the complex lives of eukaryotic mRNAs. Science 309: 1514-1518.
28. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
29. Inui M, Martello G, Piccolo S, (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
30. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
31. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
32. Shenouda SK, Alahari SK, (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28: 369-378.
33. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
34. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, et al. (2007) Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci 98: 1845-1852.
35. Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, et al. (2008) The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 68: 4034-4038.
36. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
37. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
38. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, et al. (2009) Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem 43: 150-158.
39. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2009) Identification of a MicroRNA Panel for Clear-cell Kidney Cancer. Urology 75: 835-841.
40. Kolfschoten IG, Roggli E, Nesca V, Regazzi R, (2009) Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes Metab 11 (Suppl 4): 118-129.
41. Tang X, Tang G, Ozcan S, (2008) Role of microRNAs in diabetes. Biochim Biophys Acta 1779: 697-701.
42. Schmitter D, Filkowski J, Sewer A, Pillai RS, Oakeley EJ, et al. (2006) Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res 34: 4801-4815.
43. Thomas H, Senkel S, Erdmann S, Arndt T, Turan G, et al. (2004) Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line. Nucleic Acids Res 32: e150.
44. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
45. Zhu S, Si ML, Wu H, Mo YY, (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.
46. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
47. Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, et al. (2009) UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 38: D75-D80.
48. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D, (2000) Patterns of variant polyadenylation signal usage in human genes. Genome Res 10: 1001-1010.
49. Mitchell PJ, Tjian R, (1989) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371-378.
50. Kadonaga JT, (2004) Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 116: 247-257.
51. Mignone F, Gissi C, Liuni S, Pesole G, (2002) Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004.
52. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, et al. (2010) JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 38: D105-D110.
53. Cok SJ, Morrison AR, (2001) The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276: 23179-23185.
54. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
55. Moncini S, Bevilacqua A, Venturin M, Fallini C, Ratti A, et al. (2007) The 3′ untranslated region of human Cyclin-Dependent Kinase 5 Regulatory subunit 1 contains regulatory elements affecting transcript stability. BMC Mol Biol 8: 111.
56. Sun G, Li H, Rossi JJ, (2010) Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3′UTR. Nucleic Acids Res 38: 239-252.
57. Gautreau D, Cote CA, Mowry KL, (1997) Two copies of a subelement from the Vg1 RNA localization sequence are sufficient to direct vegetal localization in Xenopus oocytes [In Process Citation]. Development 124: 5013-5020.
58. Macdonald PM, (1990) bicoid mRNA localization signal: phylogenetic conservation of function and RNA secondary structure. Development 110: 161-171.
59. Seeger MA, Kaufman TC, (1990) Molecular analysis of the bicoid gene from Drosophila pseudoobscura: identification of conserved domains within coding and noncoding regions of the bicoid mRNA. EMBO J 9: 2977-2987.
60. Scheper W, Holthuizen PE, Sussenbach JS, (1996) Growth-condition-dependent regulation of insulin-like growth factor II mRNA stability. Biochem J 318: 195-201.
61. Bentwich I, (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910.
62. Rajewsky N, (2006) L(ou)sy miRNA targets? Nat Struct Mol Biol 13: 754-755.
63. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
64. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
65. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, et al. (2010) MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285: 4415-4422.
66. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
67. Ritchie W, Flamant S, Rasko JE, (2009) Predicting microRNA targets and functions: traps for the unwary. Nat Methods 6: 397-398.
68. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
69. Hermeking H, (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199.
70. Medina PP, Slack FJ, (2008) microRNAs and cancer: an overview. Cell Cycle 7: 2485-2492.
71. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, et al. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107: 264-269.
72. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
73. Gao W, Shen H, Liu L, Xu J, Xu J, et al. (2010) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 137: 557-566.
74. Asslaber D, Pinon JD, Seyfried I, Desch P, Stocher M, et al. (2010) microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 115: 4191-4197.
75. Spizzo R, Nicoloso MS, Croce CM, Calin GA, (2009) SnapShot: MicroRNAs in Cancer. Cell 137: 586.
76. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, et al. (2010) Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 4: 51.
77. Selcuklu SD, Donoghue MT, Spillane C, (2009) miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925.
78. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48: 61-69.
79. Hatzis P, Kyrmizi I, Talianidis I, (2006) Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression. Mol Cell Biol 26: 7017-7029.